Cargando…
Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months
SIMPLE SUMMARY: There are no known effective preventative interventions for oxaliplatin-induced peripheral neuropathy (OIPN) sensory symptoms of numbness, tingling and pain other than limiting drug exposure. With the shorter 3-month duration of oxaliplatin increasingly being used, compared to the pr...
Autores principales: | Zahrieh, David, Satele, Daniel, Smith, Ellen M. Lavoie, Loprinzi, Charles L., Le-Rademacher, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909760/ https://www.ncbi.nlm.nih.gov/pubmed/35267520 http://dx.doi.org/10.3390/cancers14051212 |
Ejemplares similares
-
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020) -
Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
por: Pereira, A.F., et al.
Publicado: (2020) -
Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005) -
Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011) -
A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2018)